OSE Immunotherapeutics Presents Clinical and Preclinical Data from its Immuno-Oncology Portfolio
OSE Immunotherapeutics SA announces three presentations at the American Association for Cancer Research Annual Meeting in Orlando, April 14-19, 2023.
OSE Immunotherapeutics SA announces three presentations at the American Association for Cancer Research Annual Meeting in Orlando, April 14-19, 2023.
Glucose monitoring is a key link in diabetes management. Currently, there are two main methods for self-monitoring of glucose in patients with diabetes, one is the traditional blood glucose Monitoring, and the other is continuous glucose monitoring.
Sensorion a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, is pleased to announce its participation in two investor conferences in April 2023.
Data of InnoCare’s robust oncology pipelines were presented at the 2023 American Association for Cancer Research Annual Meeting.
Data of InnoCare’s Robust Oncology Pipelines Presented at the 2023 AACR Annual Meeting Read More »
Marlena Fejzo, una genetista que sufrió náuseas y vómitos intensos durante el embarazo, hizo de la búsqueda de la causa de su enfermedad la hiperémesis gravídica su misión de vida.
The three former board members want the board to “heed the will of shareholders,” reopen nominations and bring forth other proposals — including the option to oust one or more current board directors.
Former Cano board members request reopening of window for director nominations Read More »
Analysts from Needham and Stifel had opposite takes on how McDonald’s departure will affect the company, which has struggled in recent years to bring new products to market.
LivaNova CEO quits as firm announces higher-than-expected preliminary earnings Read More »
The mammography AI company last month said it would lay off 28% of its staff to save money.
iCAD, in midst of restructuring, names three new top executives Read More »
Lundbeck and Otsuka anticipate a favorable decision from the FDA after Adcomm voted 9–1 to add agitation in Alzheimer’s indication to the Rexulti label.
FDA Adcomm Votes in Favor of Rexulti for Agitation in Alzheimer’s Read More »
To help with your job search, here are 10 biopharma companies hiring for Artificial Intelligence and Machine Learning (AI/ML) roles now.